This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Tolerogenixx Gmbh, Universitat Heidelberg. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 34 
Years Active: 2023
Title: Caner Süsal: Innovator in Immunosuppression Therapy
Introduction
Caner Süsal is a notable inventor based in Dossenheim, Germany. He has made significant contributions to the field of transplantation through his innovative approaches to immunosuppression therapy. His work focuses on enhancing the success rates of organ and cell grafts in human recipients.
Latest Patents
Caner Süsal holds a patent for "MIC therapy for specific immunosuppression in transplantation." This invention relates to pharmaceutical compositions that utilize isolated and treated whole blood cells or Peripheral Blood Mononuclear Cells (PBMCs). These compositions are designed for the prevention and treatment of organ or cell graft rejection in human graft recipients. He has 1 patent to his name.
Career Highlights
Throughout his career, Caner Süsal has worked with prominent organizations, including Tolerogenixx GmbH and Universität Heidelberg. His experience in these institutions has allowed him to develop and refine his innovative therapies, contributing to advancements in the medical field.
Collaborations
Caner has collaborated with notable colleagues such as Christian Morath and Anita Schmitt. Their combined expertise has furthered research and development in immunosuppression therapies.
Conclusion
Caner Süsal's contributions to immunosuppression therapy represent a significant advancement in transplantation medicine. His innovative patent and collaborative efforts highlight his commitment to improving patient outcomes in organ and cell graft procedures.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile